Gestione degli effetti collaterali piu comuni dovuti alla somministrazione di amfotericina B

Translated title of the contribution: Management of amphotericin B-related adverse events

E. Castagnola, C. Viscoli

Research output: Contribution to journalArticlepeer-review


Amphotericin B represents one of the most important drugs available for antifungal therapy especially in the compromised patient. Unfortunately its administration presents many infusion-related or infusion-unrelated adverse effects, which are less frequent (but not absent) in patients receiving lipid-based formulations of amphotericin B. The present paper represents a summary of the prophylactic and therapeutic options available to manage amphotericin B related adverse events.

Translated title of the contributionManagement of amphotericin B-related adverse events
Original languageItalian
Pages (from-to)271-275
Number of pages5
JournalGiornale Italiano di Malattie Infettive
Issue number5-6
Publication statusPublished - 1999

ASJC Scopus subject areas

  • Microbiology (medical)


Dive into the research topics of 'Management of amphotericin B-related adverse events'. Together they form a unique fingerprint.

Cite this